Theravance Biopharma Inc. (TBPH) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Theravance Biopharma Inc.

    NASDAQ: TBPH · Real-Time Price · USD
    14.41
    0.34 (2.42%)
    At close: Oct 03, 2025, 3:59 PM
    14.41
    0.00%
    After-hours: Oct 03, 2025, 04:10 PM EDT

    Theravance Biopharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 64.38M 57.42M 51.35M 55.31M
    Cost of Revenue
    		 n/a n/a 6.59M 7.29M
    Gross Profit
    		 64.38M 57.42M 44.76M 48.02M
    Operating Income
    		 -46.95M -56.03M -91.96M -257.78M
    Interest Income
    		 4.88M 9.12M 8.54M 1.11M
    Pretax Income
    		 -44.61M -49.27M -92.81M -199.58M
    Net Income
    		 -56.42M -55.19M -92.82M -199.43M
    Selling & General & Admin
    		 69.17M 70.09M 67.07M 99.3M
    Research & Development
    		 37.64M 40.62M 63.39M 193.66M
    Other Expenses
    		 4.51M 2.74M n/a n/a
    Operating Expenses
    		 111.33M 113.46M 130.47M 292.95M
    Interest Expense
    		 2.55M 2.35M 6.37M 8.55M
    Selling & Marketing Expenses
    		 4.3M n/a 8M n/a
    Cost & Expenses
    		 111.33M 113.46M 130.47M 292.95M
    Income Tax Expense
    		 11.8M 5.92M 9K -151K
    Shares Outstanding (Basic)
    		 48.85M 55.3M 73.59M 69.46M
    Shares Outstanding (Diluted)
    		 48.85M 55.3M 73.59M 69.46M
    EPS (Basic)
    		 -1.15 -1 -1.26 -2.87
    EPS (Diluted)
    		 -1.15 -1 -1.26 -2.87
    EBITDA
    		 -38.45M -42.66M -79.86M -249.39M
    EBIT
    		 -42.07M -46.92M -86.45M -256.68M
    Depreciation & Amortization
    		 3.62M 4.26M 6.59M 7.29M

    Add to Watchlist